Pharmacoepidemiology Research-Real-World Evidence for Decision Making

被引：8
|
作者：
Berard, Anick [1 ,2 ,3 ]
机构：
[1] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
[2] Univ Claude Bernard Lyon 1, Fac Med, Lyon, France
[3] CHU St Justine, Montreal, PQ, Canada
来源：
FRONTIERS IN PHARMACOLOGY | 2021年 / 12卷
关键词：
pharmacoepidemiology; real-world evidence; real-world data; state-of-the-art research; decision making; data access; underrepresented populations; HEALTH; RISK;
D O I：
10.3389/fphar.2021.723427
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [41] REAL WORLD DATA AVAILABILITY IN LATIN AMERICA: ASSESSMENT AND IMPLICATIONS FOR RESEARCH AND HEALTHCARE DECISION MAKING
    Monsanto, H.
    Parellada, C.
    Orengo, J.
    Velasco, J. S.
    van Bavel, J.
    Salomonsson, S.
    [J]. VALUE IN HEALTH, 2021, 24 : S157 - S157
  • [42] Real-World Evidence: Pharmacoepidemiology for Daily Clinical Practice-An Experience from Colombia
    Enrique Machado-Alba, Jorge
    Gaviria-Mendoza, Andres
    Machado-Duque, Manuel E.
    Fernando Valladales-Restrepo, Luis
    [J]. DRUGS-REAL WORLD OUTCOMES, 2020, 7 (04) : 257 - 259
  • [43] The limitations of decision trees and automatic learning in real world medical decision making
    Zorman, M
    Stiglic, MM
    Kokol, P
    Malcic, I
    [J]. JOURNAL OF MEDICAL SYSTEMS, 1997, 21 (06) : 403 - 415
  • [44] The Limitations of Decision Trees and Automatic Learning in Real World Medical Decision Making
    Milan Zorman
    Milojka Molan Štiglic
    Peter Kokol
    Ivan Malčić
    [J]. Journal of Medical Systems, 1997, 21 : 403 - 415
  • [45] The limitations of decision trees and automatic learning in real world medical decision making
    Kokol, P
    Zorman, M
    Stiglic, MM
    Malèiæ, I
    [J]. MEDINFO '98 - 9TH WORLD CONGRESS ON MEDICAL INFORMATICS, PTS 1 AND 2, 1998, 52 : 529 - 533
  • [46] A Prospective, Real-World Evidence Study of Hyperkalemia Management Decision Making: Design of the TRACK Study
    Hsia, Judith
    Shivappa, Nitin
    Bakhai, Ameet
    Bover, Jordi
    Butler, Javed
    Ferraro, Pietro Manuel
    Fried, Linda F.
    Schneider, Markus P.
    Tangri, Navdeep
    Winkelmayer, Wolfgang C.
    Bishop, Meredith S.
    Chen, Hungta
    Jarbrink, Krister
    Rzepa, Ewelina
    Bonaca, Marc P.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 932 - 932
  • [47] Multidimensional Evidence Generation and FDA Regulatory Decision Making Defining and Using "Real-World" Data
    Jarow, Jonathan P.
    LaVange, Lisa
    Woodcock, Janet
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (08): : 703 - 704
  • [48] CONTEXT MATTERS - A TAXONOMY OF REAL-WORLD DATA AND EVIDENCE TO SUPPORT HTA DECISION-MAKING
    Murphy, L. A.
    Mestre-Ferrandiz, J.
    Sola-Morales, O.
    de Pouvourville, G.
    Cunningham, D.
    Corry, S.
    Akehurst, R.
    [J]. VALUE IN HEALTH, 2020, 23 : S622 - S622
  • [49] Role of Real-World Evidence in Clinical Decision-Making for the Management of Advanced Prostate Cancer
    Caveney, Brian
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (03): : 152 - 154
  • [50] A systematic review of coverage decision-making on health technologies-Evidence from the real world
    Fischer, Katharina Elisabeth
    [J]. HEALTH POLICY, 2012, 107 (2-3) : 218 - 230
12345